fullerene c60 has been researched along with Melanoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Z; Pan, LL; Zhang, FL; Zhang, ZZ; Zhu, XL | 1 |
| Ashcroft, JM; Hartman, KB; Marks, JW; Rosenblum, MG; Tsyboulski, DA; Weisman, RB; Wilson, LJ; Zakharian, TY | 1 |
| Deng, R; Jia, W; Li, X; Lu, Z; Wang, C; Yu, T; Zhen, M; Zhou, Y | 1 |
| Kato, S; Miwa, N; Yoshimura, T | 1 |
| Gao, J; Liu, R; Liu, Y; Ma, R; Shi, J; Wang, L; Yu, X; Zhang, J; Zhang, Z | 1 |
| Arifa, RDN; Barcelos, LS; Garcia, ZM; Krambrock, K; Ladeira, LO; Lima, RL; Madeira, MFM; Paula, TP; Pinheiro, MVB; Pinho, V; Souza, DG; Teixeira, MM; Ÿvila, TV | 1 |
| Chaudhuri, P; Mashelkar, RA; Paraskar, A; Sengupta, S; Soni, S | 1 |
| Anilkumar, P; Cao, L; Liu, JH; Lu, F; Luo, PG; Sahu, S; Sun, YP; Tackett, KN; Wang, Y | 1 |
8 other study(ies) available for fullerene c60 and Melanoma
| Article | Year |
|---|---|
Preparation and characterization of injectable Mitoxantrone poly (lactic acid)/fullerene implants for in vivo chemo-photodynamic therapy.
Topics: Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Combined Modality Therapy; Drug Carriers; Drug Liberation; Fullerenes; Injections; Lactic Acid; Male; Melanoma; Mice; Microspheres; Mitoxantrone; Phenylalanine; Photochemotherapy; Polyesters; Polymers; Xenograft Model Antitumor Assays | 2015 |
Fullerene (C60) immunoconjugates: interaction of water-soluble C60 derivatives with the murine anti-gp240 melanoma antibody.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Fullerenes; Immunoconjugates; Magnetic Resonance Spectroscopy; Melanoma; Mice; Proteoglycans | 2006 |
Light-assisted gadofullerene nanoparticles disrupt tumor vasculatures for potent melanoma treatment.
Topics: Animals; beta-Alanine; Cell Death; Chlorophyllides; Female; Fullerenes; Light; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Particle Size; Photochemotherapy; Photosensitizing Agents; Porphyrins; Singlet Oxygen; Skin Neoplasms; Surface Properties | 2020 |
Radiosensitization by Liposome-Encapsulated Fullerenes to Mitochondria/DNA-Damages on Human Melanoma Cells.
Topics: DNA; DNA Damage; Fullerenes; Humans; Liposomes; Melanoma; Mitochondria; Radiation-Sensitizing Agents; Skin Neoplasms; Tumor Cells, Cultured | 2018 |
PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Delivery Systems; Female; Ferric Compounds; Fullerenes; Hematoporphyrins; Magnetic Resonance Imaging; Melanoma; Mice; Nanocomposites; Photochemotherapy; Polyethylene Glycols | 2013 |
The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Fullerenes; Glutathione; Ileum; Interleukin-1beta; Intestinal Mucosa; Irinotecan; Leukopenia; Male; Melanoma; Mice, Inbred C57BL; Mice, Transgenic; Mucositis; Nanocomposites; Oxidative Stress; Peroxidase; Thiobarbituric Acid Reactive Substances; Tumor Burden | 2016 |
Fullerenol-cytotoxic conjugates for cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; Doxorubicin; Drug Carriers; Flow Cytometry; Fullerenes; Humans; Hydrogen-Ion Concentration; Hydroxides; Melanoma; Mice; Nanoparticles; Solubility; Water | 2009 |
Fullerenes for applications in biology and medicine.
Topics: Animals; Anti-HIV Agents; Contrast Media; Drug Carriers; Free Radical Scavengers; Fullerenes; HIV; HIV Infections; Humans; Magnetic Resonance Imaging; Melanoma; Models, Molecular; Nanomedicine; Nanostructures; Photochemotherapy; Photosensitizing Agents | 2011 |